Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”

References

[1] Smith RA,Brooks D,Manassaram-Baptiste D.Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening..CA Cancer J Clin2019;69:184-210

[2] Sturgeon CM,Chan DW,Hammond E.National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements..Clin Chem2008;54:e1-10 PMCID:PMC5564312

[3] Cohen JD,Wang Y,Afsari B.Detection and localization of surgically resectable cancers with a multi-analyte blood test..Science2018;359:926-30 PMCID:PMC6080308

[4] Lai RC,Lim SK.Membrane lipid binding molecules for the isolation of bona fide extracellular vesicle types and associated biomarkers in liquid biopsy..J Cancer Metastasis Treat2019;5:65

[5] Huang QQ,Jiang W,Wang XY.Sensitive and specific detection of circulating tumor cells promotes precision medicine for cancer..J Cancer Metastasis Treat2019;5:34

[6] Bookland MJ.Peripheral biomarkers for pediatric brain tumors: current advancements and future challenges..J Cancer Metastasis Treat2019;5:33

[7] Farlow JL,Swiecicki PL,Spector ME.Window of opportunity trials in head and neck cancer..J Cancer Metastasis Treat2019;5:18 PMCID:PMC6638557

[8] Vander Borght A,Ummelen M.Monoclonal antibodies to the exon 18 encoded moiety of NCAM..J Cancer Metastasis Treat2019;5:57

[9] Ossoliński K,Arendowski A,Ossoliński T.Mass spectrometry-based metabolomic profiling of prostate cancer - a pilot study..J Cancer Metastasis Treat2019;5:1

[10] Zaichick V.Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study)..J Cancer Metastasis Treat2018;4:60

[11] Liu CH,Sordillo LA,Sriramoju V.A pilot study for distinguishing basal cell carcinoma from normal human skin tissues using visible resonance Raman spectroscopy..J Cancer Metastasis Treat2019;5:4